Is Darunavir in shortage in 2026? Get the latest update on Darunavir availability, pricing, and what patients can do to ensure they stay on treatment.
If you or someone you care about takes Darunavir for HIV, you may have heard concerns about drug shortages affecting various medications. It's natural to wonder whether Darunavir could be next. In this article, we'll give you the latest update on Darunavir availability, explain why some patients still have trouble finding it, and share practical advice for making sure you stay on your treatment.
As of early 2026, Darunavir is not listed on the FDA's official drug shortage database. The medication — both brand-name Prezista and its multiple generic versions — remains in production and is being distributed nationwide.
Darunavir has not experienced the kind of widespread shortage that has affected other medications in recent years. The availability of multiple generic manufacturers — including Lupin, Mylan, Teva, Cipla, Aurobindo, Dr. Reddy's, and others — has helped maintain a stable supply since generics first became available in 2022.
That said, individual patients may still run into difficulty finding Darunavir at their local pharmacy. This is usually a stocking issue, not a supply issue — meaning the drug exists, but your specific pharmacy may not carry it regularly.
Even without a formal shortage, there are real-world reasons patients struggle to get Darunavir:
HIV medications like Darunavir are classified as specialty drugs. Many chain pharmacies keep only a limited supply — or none at all — on their shelves. They order it when a patient needs it, which can mean a 24- to 48-hour wait.
Brand-name Prezista and the combination products Prezcobix and Symtuza often require prior authorization from your insurance company. This approval process can take days, during which the pharmacy can't dispense the medication. Some plans may also require step therapy, meaning you must try other medications first before they'll approve Darunavir.
Pharmacies receive medications from wholesalers, who allocate supplies based on ordering history. If a pharmacy doesn't regularly order Darunavir, they may have lower priority or limited allocation from their wholesaler.
Patients in rural areas or regions with fewer HIV treatment centers may have fewer pharmacy options for specialty medications. This doesn't mean the drug is in shortage — just that access is harder in certain locations.
Cost remains a major factor in medication access. Here's a breakdown of current pricing:
For a deeper dive into saving money on this medication, read our guide on how to save money on Darunavir in 2026.
The HIV treatment landscape continues to evolve. Here are some developments worth knowing about:
Since the first generic Darunavir was approved by the FDA in 2022 (Lupin), multiple additional manufacturers have entered the market. More competition generally means lower prices and better availability for patients.
If you're taking Darunavir with separate pills for your booster and backbone medications, ask your doctor about switching to a combination product like Symtuza, which includes everything in one tablet. This can simplify your regimen and may have different availability than standalone Darunavir.
Current HIV treatment guidelines increasingly favor integrase strand transfer inhibitors (INSTIs) like Dolutegravir (Tivicay) and Bictegravir (in Biktarvy) as first-line therapy. If your treatment allows it, switching to an INSTI-based regimen may give you more pharmacy options and potentially lower costs. Explore our guide on alternatives to Darunavir for more information.
If you're having trouble finding Darunavir at your pharmacy, try these steps:
For more detailed strategies, see our full guide on how to find Darunavir in stock near you.
Darunavir remains available in 2026, and there is no formal shortage. However, the nature of specialty medication distribution means some patients may face challenges getting it from their regular pharmacy. The key is to plan ahead, use the right tools, and never skip your medication.
If cost is a barrier, programs like the Johnson & Johnson Patient Assistance Foundation, ADAP, and discount cards from GoodRx and SingleCare can dramatically reduce what you pay. And if you need to explore other treatment options, work closely with your doctor to find the right alternative for you.
Stay informed, stay proactive, and stay on your treatment. Your health depends on it.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
